XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 324 $ 328
Short-term investments 5 4
Accounts receivable, net 1,431 1,130
Inventories 1,306 1,172
Prepaid expenses 63 63
Total current assets 3,129 2,697
Property, plant and equipment, net of accumulated depreciation of $3,304 and $3,232, respectively 2,446 2,423
Intangible assets, net of accumulated amortization of $259 and $253, respectively 1,339 1,348
Other assets 521 531
Total assets 7,435 6,999
Current liabilities:    
Short-term borrowings 514 308
Accounts payable and accrued liabilities 1,207 1,204
Total current liabilities 1,721 1,512
Long-term debt 1,739 1,738
Other non-current liabilities 561 524
Total liabilities 4,021 3,774
Share-based payments subject to redemption 31 36
Redeemable non-controlling interests 71 71
Ingredion stockholders' equity:    
Preferred stock - authorized 25,000,000 shares - $0.01 par value, none issued
Common stock - authorized 200,000,000 shares - $0.01 par value, 77,810,875 issued at March 31, 2022 and December 31, 2021 1 1
Additional paid-in capital 1,160 1,158
Less: Treasury stock (common stock: 11,464,034 and 11,154,203 shares at March 31, 2022 and December 31, 2021, respectively) at cost (1,091) (1,061)
Accumulated other comprehensive loss (763) (897)
Retained earnings 3,986 3,899
Total Ingredion stockholders' equity 3,293 3,100
Non-redeemable non-controlling interests 19 18
Total equity 3,312 3,118
Total liabilities and equity $ 7,435 $ 6,999